These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11111978)

  • 1. Liver transplantation for alcoholic cirrhosis.
    Platz KP; Mueller AR; Spree E; Schumacher G; Nüssler NC; Rayes N; Glanemann M; Bechstein WO; Neuhaus P
    Transpl Int; 2000; 13 Suppl 1():S127-30. PubMed ID: 11111978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance.
    Berlakovich GA; Steininger R; Herbst F; Barlan M; Mittlböck M; Mühlbacher F
    Transplantation; 1994 Sep; 58(5):560-5. PubMed ID: 8091482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Jun; 9(3 Pt 1):176-84. PubMed ID: 7549057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism.
    Pageaux GP; Michel J; Coste V; Perney P; Possoz P; Perrigault PF; Navarro F; Fabre JM; Domergue J; Blanc P; Larrey D
    Gut; 1999 Sep; 45(3):421-6. PubMed ID: 10446113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.
    Platz KP; Mueller AR; Jonas S; Blumhardt G; Bechstein WO; Lobeck H; Neuhaus HL
    Clin Transplant; 1995 Jun; 9(3 Pt 1):146-54. PubMed ID: 7549052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for the optimal management of hepatitis C patients after liver transplantation.
    Platz KP; Mueller AR; Berg T; Neuhaus R; Hopf U; Lobeck H; Neuhaus P
    Transpl Int; 1998; 11 Suppl 1():S209-11. PubMed ID: 9664981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute steroid-resistant rejection after liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lemmens P; Lobeck H; Neuhaus P
    World J Surg; 1996 Oct; 20(8):1052-8; discussion 1058-9. PubMed ID: 8798364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation for alcoholic cirrhosis: how does recurrence of disease harm the graft?
    Berlakovich GA; Steininger R; Herbst F; Barlan M; Mittlböck M; Mühlbacher F
    Transpl Int; 1994; 7 Suppl 1():S123-7. PubMed ID: 11271184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.
    Singal AK; Bashar H; Anand BS; Jampana SC; Singal V; Kuo YF
    Hepatology; 2012 May; 55(5):1398-405. PubMed ID: 22213344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric liver transplantation. A single center experience spanning 20 years.
    Jain A; Mazariegos G; Kashyap R; Kosmach-Park B; Starzl TE; Fung J; Reyes J
    Transplantation; 2002 Mar; 73(6):941-7. PubMed ID: 11923697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up of a trial comparing Tacrolimus and cyclosporine microemulsion in liver transplantation.
    González-Pinto IM; Rimola A; Margarit C; Cuervas-Mons V; Abradelo M; Alvarez-Laso C; Londoño MC; Bilbao I; Sánchez-Turrión V
    Transplant Proc; 2005 May; 37(4):1713-5. PubMed ID: 15919441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A; Reyes J; Kashyap R; Rohal S; Abu-Elmagd K; Starzl T; Fung J
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplantation; 1998 Apr; 65(8):1044-6. PubMed ID: 9583863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study.
    Vassallo GA; Tarli C; Rando MM; Mosoni C; Mirijello A; Agyei-Nkansah A; Antonelli M; Sestito L; Perotti G; Di Giuda D; Agnes S; Grieco A; Gasbarrini A; Addolorato G;
    Alcohol Alcohol; 2018 Mar; 53(2):151-156. PubMed ID: 29206894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.
    Mueller AR; Platz KP; Bechstein WO; Blumhardt G; Lobeck H; Hop U; Neuhaus P
    Transplant Proc; 1994 Dec; 26(6):3637-9. PubMed ID: 7527984
    [No Abstract]   [Full Text] [Related]  

  • 20. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.